GlassScriptPhysician profile
Hallie Rae Hahn
NPI 1083238133
$5,096.56
in general payments reported to CMS, 2019-2025
20 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $356 · 2022: $1,328 · 2023: $1,408 · 2024: $1,779 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,866 · Charitable Contribution: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,865.69 |
| Charitable Contribution | $546.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,187.55 | 2022-2025 | Clareon, Hydrus Microstent, Ngenuity |
| Johnson & Johnson Surgical Vision, INC. | $862.30 | 2021-2024 | Tecnis Iol, Veritas Vision System |
| Microsurgical Technology, INC. | $546.29 | 2024 | |
| Abbvie INC. | $436.13 | 2022-2024 | |
| Glaukos Corporation | $299.03 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $296.00 | 2022-2024 | Envista Mx60 Iol, Stellaris |
| Sight Sciences, INC. | $205.30 | 2021-2022 | |
| Harrow Eye, LLC | $145.81 | 2024-2025 | Flarex, Verkazia, Iheezo |
| Genentech, INC. | $136.97 | 2023 | Vabysmo |
| Rxsight INC | $135.98 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Axogen | $121.30 | 2023 | Avance Nerve Graft |
| Regeneron Healthcare Solutions, INC. | $114.15 | 2024 | Eylea Hd |
| Horizon Therapeutics Plc | $111.57 | 2022 | |
| Allergan, INC. | $99.99 | 2021 | |
| Astellas Pharma US INC | $98.68 | 2024 | Izervay |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $96.39 | 2023 | Forum |
| Tarsus Pharmaceuticals, INC. | $87.35 | 2025 | Xdemvy |
| Dompe US, INC. | $49.91 | 2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $49.46 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hallie Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.